Otto W.M. Meijer
Papers
1
Total Citations
30
H-Index
1
About
Dr. Otto W.M. Meijer is a leading radiation oncologist whose research focuses on advancing precision radiotherapy for prostate cancer, particularly through the integration of molecular imaging. His major contributions center on demonstrating the clinical utility of prostate-specific membrane antigen (PSMA) PET/CT in guiding salvage radiation therapy for men with biochemically recurrent disease. In his landmark 2022 study, Dr. Meijer showed that PSMA PET/CT-guided salvage treatment significantly improves oncological outcomes compared to conventional imaging approaches, with 30 citations underscoring its impact. By enabling more accurate detection of recurrent tumor deposits, his work has directly changed clinical management paradigms, allowing for tailored radiation fields and dose escalation. Dr. Meijer’s research bridges the gap between advanced imaging technology and practical radiotherapy delivery, offering patients better disease control and reduced toxicity. His contributions have been instrumental in establishing PSMA PET/CT as a standard tool in the salvage setting, influencing international guidelines and improving outcomes for thousands of men worldwide.
Research Focus
Key Achievements
Top Papers
- 1